Brown Adipose Tissue as a Unique Niche for Islet Organoid Transplantation: Insights From In Vivo Imaging
Authors:
- Aixia SunASAixia Sun
- Hanaan Bs HayatHHHanaan Bs Hayat
- Elizabeth KenyonEKElizabeth Kenyon
- Tahnia Bs QuadriTQTahnia Bs Quadri
- Darius Bs AmosDADarius Bs Amos
- Keenan Bs PerkinsKPKeenan Bs Perkins
- Saumya NigamSNSaumya Nigam
- Deanna Bs TarletonDTDeanna Bs Tarleton
- Christiane L. MallettCMChristiane L. Mallett
- Cheri X. DengCDCheri X. Deng
- Zhen QiuZhen Qiu
- Wen LiWLWen Li
Open Access
- 13 June 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 10 (7) , e1658
Abstract
Background.: Transplantation of human-induced pluripotent stem cell (hiPSC)-derived islet organoids is a promising cell replacement therapy for type 1 diabetes (T1D). It is important to improve the efficacy of islet organoids transplantation by identifying new transplantation sites with high vascularization and sufficient accommodation to support graft survival with a high capacity for oxygen delivery. Methods.: A human-induced pluripotent stem cell line (hiPSCs-L1) was generated constitutively expressing luciferase. Luciferase-expressing hiPSCs were differentiated into islet organoids. The islet organoids were transplanted into the scapular brown adipose tissue (BAT) of nonobese diabetic/severe combined immunodeficiency disease (NOD/SCID) mice as the BAT group and under the left kidney capsule (KC) of NOD/SCID mice as a control group, respectively. Bioluminescence imaging (BLI) of the organoid grafts was performed on days 1, 7, 14, 28, 35, 42, 49, 56, and 63 posttransplantation. Results.: BLI signals were detected in all recipients, including both the BAT and control groups. The BLI signal gradually decreased in both BAT and KC groups. However, the graft BLI signal intensity under the left KC decreased substantially faster than that of the BAT. Furthermore, our data show that islet organoids transplanted into streptozotocin-induced diabetic mice restored normoglycemia. Positron emission tomography/MRI verified that the islet organoids were transplanted at the intended location in these diabetic mice. Immunofluorescence staining revealed the presence of functional organoid grafts, as confirmed by insulin and glucagon staining. Conclusions.: Our results demonstrate that BAT is a potentially desirable site for islet organoid transplantation for T1D therapy.Keywords
This publication has 43 references indexed in Scilit:
- Engineering pancreatic islets with a novel form of thrombomodulin protein to overcome early graft loss triggered by instant blood-mediated inflammatory reactionAmerican Journal of Transplantation, 2023
- In Vivo Bioluminescence for the Detection of the Fate of Pancreatic Islet Organoids Post-transplantation2022
- From the dish to humans: A stem cell recipe for successCell Metabolism, 2022
- Modulating mesendoderm competence during human germ layer differentiationCell Reports, 2021
- Islet organoid as a promising model for diabetesProtein & Cell, 2021
- Enhanced structure and function of human pluripotent stem cell-derived beta-cells cultured on extracellular matrixStem Cells Translational Medicine, 2020
- Artificial Intelligence Analysis of Magnetic Particle Imaging for Islet Transplantation in a Mouse ModelMolecular Imaging and Biology, 2020
- Human Induced Pluripotent Stem Cells in the Curative Treatment of Diabetes and Potential Impediments Ahead2018
- Immunomodulatory and protective effects of adipose tissue-derived mesenchymal stem cells in an allograft islet composite transplantation for experimental autoimmune type 1 diabetesImmunology Letters, 2017
- Generation of Functional Human Pancreatic β Cells In VitroCell, 2014